Skip to main content
Premium Trial:

Request an Annual Quote

Carl Zeiss Unit and Qiagen Form Technology Collaboration

NEW YORK, Sept. 16 (GenomeWeb News) - P.A.L.M. Microlaser Technologies and Qiagen will collaborate to provide technologies and products for biological and medical research.


A key technology of P.A.L.M., a subsidiary of Carl Zeiss, is its Laser Microdissection and Pressure Catapulting technology which enables touch-free transport of target samples. The method aims for contamination-free specimens, according to P.A.L.M.


According to the companies, P.A.L.M.'s laser microdissection systems combined with Qiagen's reagents and components should lead to more precise specimen preparation and a new quality of analytical examinations.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.